Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday
Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...
Novo Nordisk: Be Greedy When Others Are Fearful
Novo Nordisk retains a strong market position in a high-growth industry, with P/E multiples poised to expand. See why NVO ...
Novo Nordisk Stock Rises as UBS Upgrades Ozempic Maker, Calls Sell-Off 'Overdone'
Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...
FierceBiotech6d
Novo Nordisk doubles down on Valo, betting $190M near-term to apply AI to obesity and diabetes
Novo Nordisk is doubling down on its collaboration with Valo Health, committing up to $190 million in near-term payments—and ...
Yahoo Finance10h
Portugal Probes Ex-Novo Banco Official’s Large Cash Bank Deposit
(Bloomberg) -- Police in Portugal are investigating the origin of large amounts of cash deposited in Portuguese banks by ...
Novo Nordisk Expands AI Partnership With Valo Health for Development of Obesity Drugs
Novo and Valo originally partnered in September 2023 in an agreement to develop up to 11 drugs. With the expanded agreement, ...
Ghanaweb.com1d
A Ghanaian afrobeat singer,songwriter LEEDO BEB released a elctrifying new single title ''Sinner'' ft Novo.
New Music Alert: @LEEDOBEBMUSIC Drop's Electrifying New Single "SINNER" ft Novo Get ready to groove to the latest offering ...
Better Buy: Novo Nordisk vs. AstraZeneca
Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...
Seattle genomics startup Variant Bio signs deal with Novo Nordisk worth up to $50M
Variant Bio is partnering with Novo Nordisk to study metabolic diseases including obesity, using Variant's genomic data from ...
FierceBiotech4d
Novo Holdings-backed Windward generates $200M series A, inks $970M biobucks deal for clinical antibody
Windward Bio has landed with a flurry of announcements, circling in a $200 million series A and offering up to $970 million ...